- Country of manufactureIndia
- Dosage formPills
Packing - 1*28 Tablet
Company – Zydus
contain - Sofosbuvir
Sovihep is marketed and Manufactured by Gilead Zydus. Sovihep contain Sofosbuvir 400mg .
Sofosbuvir Is indicated for the treament fo Hepatitis C. Sovihep also can be use for the treatment of HCV & HIV coinfections. Hepatitis C is a liver disease caused by the hepatitis C virus the virus can cause both acute and chronic hepatitis infection, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness.
The hepatitis C virus is a blood borne virus and the most common modes of infection are through unsafe injection practices, inadequate sterilization of medical equipment, and the transfusion of unscreened blood and blood products.
Globally, between 130–150 million people globally have chronic hepatitis C infection.
A significant number of those who are chronically infected will develop liver cirrhosis or liver cancer.
There is currently no vaccine for hepatitis C; however research in this area is ongoing.
The hepatitis C virus is a bloodborne virus. It is most commonly transmitted through:
# injecting drug use through the sharing of injection equipment;
# The reuse or inadequate sterilization of medical equipment, especially syringes and needles in healthcare settings; and the transfusion of unscreened blood and blood products.
Sovihep Sofosbuvir should be used in combination with ribavirin , Daclastavir, or with pegylated interferon
Sofosbuvir is effective for the treatment of HCV in Genotyp 1 ,Genotype 2 ,Genotype 3 , Genotype 4.
Sofosbuvir and ribavirin therapy for 24 weeks can be considered for patients with genotype 1
SOVIHEP is a hepatitis C virus (HCV) nucleotide analog NS5B polymerase inhibitor
Natdac is a hepatitis C virus (HCV) inhibitor indicated for use with or without ribavirin, for the treatment of chronic HCV genotype 1 or 3 infection.
The recommended dose of SOVIHEP 400mg mg tablet once daily , taken orally, with or without food . & Ribavarin dose is for the patient less then or equal to 75 kg is 1000mg and more then or equal to 75 kg is 1200mg.
Sovihep in combination with ribavarin for 24weeks can be given to the Genotype 1 Patient who are interferone ineligible.
For genotype 2 patient treatment -naive and treatment experienced without cirrhosis or with compensated cirrhosis Sovihep And Ribavarin should be gibven for 12 weeks
In Genotype 3 patient Treatment naive and treatment experienced without cirrhosis or with compensated cirrhosis Sofosbuvir and Ribavarin should be given for 24 weeks
Most common adverse reactions observed with Sofosbuvir in combination with Ribavarin is headache and fatigue.
Storage : Sovihep should be stored at room temperature between 20°C and 25°C
The black box warning of Sovihep is Hepatitis B virus reactivation . Hepatitis B Virus could become active again during or after HCV treatment with Sovihep.
K M healthcare is trader , Exporter or supplier of Sovihep Sofosbuvir Tablet. .
KM Healthcare supply Hepatitis C Medicines Sovihep, Hepcinat, Hepcinat Lp , Myhep, Myhep Lvir at very affordable price.
We export of Sofosbuvir Tablet to Russia, China, Belarus, Kazakhstan, Ukraine, Georgia , Cambodia, Vietnam , China , Armenia , Belarus , Moldova , Tajakistan , Romania , Minsk ,Uzbekistan , Moscow , Kiev, African Countries, Afganiztan , Istambul, Uk , Germany , Hongkong , Iran , Itlay, and many more countries and cities.